GSK announced today that Health Canada has approved Nucala (mepolizumab) as an add-on maintenance treatment in adult patients ...
Elevated sputum azurocidin-1 levels correlate with worsening lung function and increased exacerbation frequency in patients with bronchiectasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results